If you're looking to uncover family history or learn more about your health, here's how to decide which DNA testing kit is ...

RALEIGH, North Carolina (WTVD) -- DNA testing can be a fun way to unlock the mysteries of your family history, but you should also think about potential pitfalls. Tisha Powell and I decided to embark ...

23andMe, a popular direct-to-consumer genetic testing company, made headlines after its CEO pledged to help reunite the more than 2,300 children separated from their parents at the U.S.’s southern ...

Tarrytown-based Regeneron would acquire 23andMe for $256 million under the deal that is pending approval by bankruptcy court and regulators. New York-based biotech giant Regeneron Pharmaceuticals ...

Oregonians, along with residents of three other states, could receive a $100 cash payment in addition to other settlement ...

Regeneron Pharmaceuticals will acquire 23andMe's assets for $256 million, both companies said. 23andMe filed for Chapter 11 bankruptcy earlier this year. The DNA testing company has faced major ...

23andMe, which sold saliva collection kits to consumers wanting insight into their genetic background, filed for bankruptcy in March 2025. The company has now agreed to sell its data bank to Regeneron ...

New York and other states filed a lawsuit seeking to block 23andMe, the bankrupt genetic testing firm, from selling millions of Americans' genetic data to the highest bidder. A total of 28 state ...

Direct-to-consumer genetic testing now a booming industry—and it’s easy to see why. A simple swap of the inside of your mouth can provide you with insights into your ethnicity, health, and long-lost ...

Genetic testing company 23andMe laid off 100 employees on Jan. 23 due to decreasing sales of its direct-to-consumer DNA test kits, CNBC reports. The layoffs, which affect about 14 percent of the ...

Discover more in 50 Times People Took A DNA Test And Found Out More Than They Wanted To Click here & follow us for more lists, facts, and stories.

New York-based biotech giant Regeneron Pharmaceuticals announced May 19 its plan to purchase the bankrupt genetic testing firm 23andMe in a $256 million deal that could include millions of Americans' ...